JHLT OpenPub Date : 2026-02-01Epub Date: 2025-11-21DOI: 10.1016/j.jhlto.2025.100444
Charounipha Soydara NP-C , Ilya Giverts MD , Catharine L. Griskowitz BS , Isabela Landsteiner MD , Kamila Drezek BS , Alexandra Minasian MS , Tara L. Logan BSN , Janice Camuso BSN , Alexandra E. Dempsey BSN , Katherine Milley NP, MSN , Asishana A. Osho MD, MPH , Eriberto Michel MD , Erin Coglianese MD , Ioannis Mastoris MD , David A. D’Alessandro MD , Corrine Y. Jurgens PhD, RN, FHFSA , Gregory D. Lewis MD , Van-Khue Ton MD, PhD
{"title":"Novel markers of myocardial recovery in patients with left ventricular assist device: A cardiopulmonary exercise test and hemodynamic analysis","authors":"Charounipha Soydara NP-C , Ilya Giverts MD , Catharine L. Griskowitz BS , Isabela Landsteiner MD , Kamila Drezek BS , Alexandra Minasian MS , Tara L. Logan BSN , Janice Camuso BSN , Alexandra E. Dempsey BSN , Katherine Milley NP, MSN , Asishana A. Osho MD, MPH , Eriberto Michel MD , Erin Coglianese MD , Ioannis Mastoris MD , David A. D’Alessandro MD , Corrine Y. Jurgens PhD, RN, FHFSA , Gregory D. Lewis MD , Van-Khue Ton MD, PhD","doi":"10.1016/j.jhlto.2025.100444","DOIUrl":"10.1016/j.jhlto.2025.100444","url":null,"abstract":"<div><h3>Background</h3><div>Left ventricular assist device (LVAD)-associated myocardial recovery is possible. Beyond peak O<sub>2</sub> consumption (pVO<sub>2</sub>), parameters obtained from cardiopulmonary exercise testing (CPET), such as post exercise oxygen uptake recovery delay (VO<sub>2</sub>RD), ventilatory efficiency (V<sub>E</sub>/VCO<sub>2</sub> slope), and pressure-flow slopes from invasive hemodynamics, may offer novel insights in recovery assessment.</div></div><div><h3>Methods</h3><div>We performed a retrospective analysis of 46 LVAD recipients with CPET (2014-2024), of whom 5 had complete recovery and LVAD explant (recovered group). A subset (<em>n</em> = 23) had invasive hemodynamics during CPET. VO<sub>2</sub>RD thresholds were defined as the time required for VO<sub>2</sub> to fall below 12.5%, 25%, and 50% of pVO<sub>2</sub> (T<sub>12.5%</sub>, T<sub>25%</sub>, T<sub>50%</sub>). Pressure-flow slopes were derived by regressing pulmonary artery wedge pressure (PAWP) and mean pulmonary artery pressure (PAP) against cardiac output (CO) throughout exercise.</div></div><div><h3>Results</h3><div>Compared to nonrecovered group, recovered patients had higher left ventricular ejection fraction (47% [45-48] vs 19% [16-28], <em>p</em> = 0.001), higher pVO<sub>2</sub> (14.0 [13.6-20.6] vs 11.0 [9.9-12.3] ml/kg/min, <em>p</em> = 0.007), shorter VO<sub>2</sub>RD thresholds (T<sub>12.5%</sub>: 31.4 ± 11.7 vs 47.7 ± 19.1 s, <em>p</em> = 0.03; T<sub>25%</sub>: 46.8 ± 7.1 vs 65.3 ± 25 s, <em>p</em> = 0.0038; T<sub>50%</sub>: 82 ± 10.1 vs 99.6 ± 20.9 s, <em>p</em> = 0.027), lower PAWP/CO (1.1 vs 3.6 mm Hg/liter/min, <em>p</em> = 0.003) and PAP/CO (2.4 vs 4.3 mm Hg/liter/min, <em>p</em> = 0.03) slopes. V<sub>E</sub>/VCO<sub>2</sub> slope components in all exercise phases were similar.</div></div><div><h3>Conclusions</h3><div>VO<sub>2</sub>RD and pressure-flow slopes were lower in recovered patients, and could be incorporated into a prospective wean protocol assessing for complete myocardial recovery in LVAD-supported patients.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"11 ","pages":"Article 100444"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145736372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-02-01Epub Date: 2025-11-15DOI: 10.1016/j.jhlto.2025.100440
Boateng Kubi MD, MPH , Ruby Singh MD, MPH , Elsayed Elsafy BS , Orit Abrahim MD, MPH , Lucy Nam MD , Akash Premkumar MD , Stevens Bontemps BS , Dane C. Paneitz MD, MPH , Marlena Sabatino MD , Eriberto Michel MD , Asishana A. Osho MD, MPH
{"title":"Demographic differences in complication and failure to rescue rates following lung transplantation","authors":"Boateng Kubi MD, MPH , Ruby Singh MD, MPH , Elsayed Elsafy BS , Orit Abrahim MD, MPH , Lucy Nam MD , Akash Premkumar MD , Stevens Bontemps BS , Dane C. Paneitz MD, MPH , Marlena Sabatino MD , Eriberto Michel MD , Asishana A. Osho MD, MPH","doi":"10.1016/j.jhlto.2025.100440","DOIUrl":"10.1016/j.jhlto.2025.100440","url":null,"abstract":"<div><h3>Background</h3><div>We evaluated the association between race/ethnicity and failure to rescue (FTR) following lung transplantation.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study of 34,184 patients undergoing primary lung transplantation (2006–2024). Race/ethnicity was categorized as non-Hispanic White (81.3%), non-Hispanic Black (9.5%), and Hispanic (9.1%). The primary outcome was FTR. Logistic regression identified predictors of FTR, while Cox proportional hazards models assessed the association between race/ethnicity and outcomes.</div></div><div><h3>Results</h3><div>Black patients experienced the highest rates of postoperative complications (26.3%) compared to non-Hispanic White (17.9%) and Hispanic patients (19.6%) (p < 0.001). Mortality rate was also highest among Black patients (6.8%) compared to White (5.0%) and Hispanic patients (4.8%) (p <0.001). However, race/ethnicity was not independently associated with FTR. Risk factors for FTR included dialysis at transplant (OR 2.05, 95% CI: 1.28–3.29, p=0.003), double lung transplant (OR 1.30, 95% CI: 1.09–1.56, p=0.004), and prolonged ischemic time (OR 1.05, 95% CI: 1.02–1.08, p=0.001).</div></div><div><h3>Conclusions</h3><div>While Black patients experienced higher complication and mortality rates, race/ethnicity was not independently linked to FTR after lung transplantation.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"11 ","pages":"Article 100440"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145684601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Antimicrobial pharmacokinetics and stewardship in critically Ill adult patients receiving ECMO: Challenges, evidence, and future directions","authors":"A.L. Dzierba Pharm.D., FCCP, FCCM, FASHP , Y-H. Liang , H. Lyster PhD, FRPharmS, FFRPS","doi":"10.1016/j.jhlto.2025.100438","DOIUrl":"10.1016/j.jhlto.2025.100438","url":null,"abstract":"<div><div>Infection is a common indication and complication for extracorporeal membrane oxygenation (ECMO), and adult ECMO recipients face increased nosocomial infection risk. Effective antimicrobial dosing in these patients remains difficult due to pharmacokinetic (PK) and pharmacodynamic (PD) alterations driven by critical illness and extracorporeal circuits. In this narrative review we aim to discuss the potential impact of ECMO on antimicrobial PK and dosing requirements. Findings across studies show heterogeneity in dosing practices and indicate that inter-patient variability is influenced more by critical illness and organ dysfunction than ECMO alone. Standardized dosing protocols remain lacking, and in the absence of robust guidelines, current best practice involves applying PK/PD principles, using therapeutic drug monitoring, and individualizing dosing strategies. Across all antimicrobial drug classes, robust prospective studies linking PK/PD targets to clinical outcomes are lacking. Future research should focus on prospective trials correlating dosing regimens with meaningful clinical endpoints to refine evidence-based antimicrobial guidance. These efforts are essential to developing evidence-based dosing recommendations and optimizing antimicrobial stewardship in this high-risk population.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"11 ","pages":"Article 100438"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145684706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-02-01Epub Date: 2025-11-01DOI: 10.1016/j.jhlto.2025.100423
Isaac S. Alderete MD MHS , Samantha E. Halpern MD MHS , Oliver K. Jawitz MD MHS , Ahmed Gurses MD , Haoran Jiang , Hiroshi Date MD , Jacob Klapper MD MHS , Matthew G. Hartwig MD MHS , Kunal J. Patel MD PhD
{"title":"Lung transplantation from donation after circulatory death donors over 55 years old: A national analysis of outcomes and utilization","authors":"Isaac S. Alderete MD MHS , Samantha E. Halpern MD MHS , Oliver K. Jawitz MD MHS , Ahmed Gurses MD , Haoran Jiang , Hiroshi Date MD , Jacob Klapper MD MHS , Matthew G. Hartwig MD MHS , Kunal J. Patel MD PhD","doi":"10.1016/j.jhlto.2025.100423","DOIUrl":"10.1016/j.jhlto.2025.100423","url":null,"abstract":"<div><h3>Background</h3><div>Lungs from older donation after circulatory death (DCD) donors are underutilized; however, these organs may represent an opportunity to expand the donor pool. Herein, we evaluated utilization and outcomes of lung transplants using lungs from older DCD donors.</div></div><div><h3>Methods</h3><div>Using national data from 2016 to 2024, we identified all adult DCD donors and corresponding isolated lung transplant recipients. Multivariable logistic regression was used to identify predictors of lung utilization. Kaplan-Meier and Cox proportional hazards methods were used to compare graft survival between recipients of lungs from DCD donors <55 and ≥55 years.</div></div><div><h3>Results</h3><div>Among 10,769 older (age ≥ 55) DCD donors identified, lungs were transplanted from only 302 (2.8%) with significant organ procurement organization- and center-level variation in use. Just one center exceeded 50 transplants using older DCD donors over the study period. Utilization increased over time (7 cases in 2016 vs 111 in 2024; <em>p</em> < 0.001). Ex-vivo lung perfusion (odds ratio 5.93) and higher PaO₂/FiO₂ ratio (odds ratio 1.33 per 50-point increase) were independently associated with transplantation of older DCD donor lungs. One- and three-year graft survival were similar between age groups; older donor age was not associated with increased risk of graft failure in adjusted models.</div></div><div><h3>Conclusions</h3><div>Lungs from older DCD donors remain underutilized despite comparable outcomes. Their use is highly concentrated among a small number of centers and organ procurement organizations, suggesting that local behaviors and infrastructure strongly influence disposition. Broader adoption of ex-vivo lung perfusion and strategic recipient matching may support safe expansion of this untapped donor pool.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"11 ","pages":"Article 100423"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145571803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-02-01Epub Date: 2025-11-15DOI: 10.1016/j.jhlto.2025.100442
Emmanuel Odekunle BS , Adham Makarem MD, MPH , George Olverson BS , Kamila Drezek BS , Eriberto Michel MD , David D’Alessandro MD , Ioannis Mastoris MD , Shannon N. Tessier PhD , Asishana Osho MD, MPH , S. Alireza. Rabi MD, PhD
{"title":"Impact of initial hematocrit levels during direct procurement and perfusion on the likelihood of primary graft dysfunction in donation after circulatory death heart transplantation","authors":"Emmanuel Odekunle BS , Adham Makarem MD, MPH , George Olverson BS , Kamila Drezek BS , Eriberto Michel MD , David D’Alessandro MD , Ioannis Mastoris MD , Shannon N. Tessier PhD , Asishana Osho MD, MPH , S. Alireza. Rabi MD, PhD","doi":"10.1016/j.jhlto.2025.100442","DOIUrl":"10.1016/j.jhlto.2025.100442","url":null,"abstract":"<div><h3>Background</h3><div>Optimizing perfusion parameters when using ex vivo heart perfusion systems is critical for maximizing organ quality and extending perfusion duration. Hematocrit (HCT) of the perfusate may influence oxygen delivery and perfusion dynamics, yet its clinical significance remains uncertain.</div></div><div><h3>Methods</h3><div>In this retrospective single-center study, we utilize regression models to explore the relationship between hematocrit (HCT) of the device perfusate during normothermic machine perfusion (using the Transmedics Organ System [OCS]) and recipient outcomes following transplantation. Cohorts with HCT <15% packed cell volume [PCV] were compared with those with HCT ≥15% PCV.</div></div><div><h3>Results</h3><div>Among 74 recipients, moderate and severe primary graft dysfunction (defined as needing extracorporeal machine oxygenation post-transplant) did not differ significantly between cohorts. Mean inotrope scores 48 hours post admission were significantly higher in recipients with higher perfusate HCT. The ICU length of stay in the higher HCT group was numerically high but did not achieve statistical significance.</div></div><div><h3>Conclusion</h3><div>Higher perfusate HCT was not associated with reduced PGD and may be linked to increased postoperative support requirements. These findings raise important questions about optimal HCT levels for ex vivo perfusion and warrant further prospective investigation.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"11 ","pages":"Article 100442"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145789608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-02-01Epub Date: 2025-12-03DOI: 10.1016/j.jhlto.2025.100461
Laurent Godinas , Michaela Orlitová , Emanuele Muscogiuri , Laurens J. Ceulemans , Elie Fadel , Marion Delcroix , Tom Verbelen
{"title":"Lung transplantation for chronic thromboembolic pulmonary hypertension","authors":"Laurent Godinas , Michaela Orlitová , Emanuele Muscogiuri , Laurens J. Ceulemans , Elie Fadel , Marion Delcroix , Tom Verbelen","doi":"10.1016/j.jhlto.2025.100461","DOIUrl":"10.1016/j.jhlto.2025.100461","url":null,"abstract":"<div><div>Therapeutic advances in chronic thromboembolic pulmonary hypertension (CTEPH) over the last 10 years have improved patient prognosis. As a result, the role of lung transplantation (LTx) for this indication has been greatly reduced. In this review article, we describe the evolution of treatments for CTEPH, the place that remains for lung transplantation, and the particularities of lung transplantation for this indication.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"11 ","pages":"Article 100461"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145839581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-02-01Epub Date: 2025-10-04DOI: 10.1016/j.jhlto.2025.100392
Antonio Coppolino , Rie Maurer , Ella Woehl , Erin M. Connolly , Elene Chamberlin , Hilary J. Goldberg , Selvin S. Jacob , Stefi F. Lee , John C. Kennedy , Adil Sheikh , Audra J. O’Neill , Simran Gupta , Ruben A. Hernandez Acosta , Victor Kovac , Mohamed Keshk , Amy Hackmann , John Dunning , Nirmal S. Sharma , Lindsey R. Baden , Ann E. Woolley
{"title":"Bronchial stenosis after lung transplant: Risk factors and clinical outcomes","authors":"Antonio Coppolino , Rie Maurer , Ella Woehl , Erin M. Connolly , Elene Chamberlin , Hilary J. Goldberg , Selvin S. Jacob , Stefi F. Lee , John C. Kennedy , Adil Sheikh , Audra J. O’Neill , Simran Gupta , Ruben A. Hernandez Acosta , Victor Kovac , Mohamed Keshk , Amy Hackmann , John Dunning , Nirmal S. Sharma , Lindsey R. Baden , Ann E. Woolley","doi":"10.1016/j.jhlto.2025.100392","DOIUrl":"10.1016/j.jhlto.2025.100392","url":null,"abstract":"<div><h3>Background</h3><div>Bronchial stenosis is a known complication after lung transplantation, but risk factors remain incompletely understood. We identified predictors of bronchial stenosis requiring bronchoscopic intervention, with a focus on post-transplant bacterial infections, and its impact on clinical outcomes.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study of 342 adult lung transplant recipients at a single center between 2017 and 2023. Bronchial stenosis was defined as localized airway narrowing requiring intervention. Clinical, perioperative, and infectious variables—censored to precede the onset of stenosis—were analyzed using univariate and multivariable logistic regression. Outcomes included survival, acute cellular and antibody-mediated rejection, and chronic lung allograft dysfunction (CLAD).</div></div><div><h3>Results</h3><div>Thirty-four patients (9.9%) developed bronchial stenosis requiring intervention. Multivariable analysis identified male sex (OR: 2.77, 95% CI: 1.13–6.79, <em>p</em> = 0.0261), pulmonary graft dysfunction (PGD) (OR: 3.45, 95% CI: 1.23–9.69, <em>p</em> = 0.0190), length of index hospitalization (OR: 1.01, 95% CI: 1.00–1.02, <em>p</em> = 0.0479), and any positive post-transplant bacterial respiratory culture—prior to onset of stenosis—(OR: 3.97, 95% CI: 1.67–9.48, <em>p</em> = 0.0019) as independent risk factors. Pneumonia and colonization with <em>Pseudomonas aeruginosa</em> or other gram-negatives were strongly associated with stenosis, while <em>Staphylococcus aureus</em> infections and colonization were not. Bronchial stenosis did not significantly impact survival, rejection, or CLAD incidence.</div></div><div><h3>Conclusions</h3><div>Bronchial stenosis following lung transplantation is associated with PGD and bacterial airway infections, particularly <em>Pseudomonas</em> species or other gram negatives. These findings support an association between early gram-negative bacterial airway infections and bronchial stenosis and highlight the need for infection prevention and further prospective studies to clarify causal mechanisms and guide targeted interventions.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"11 ","pages":"Article 100392"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146026122","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-02-01Epub Date: 2025-12-23DOI: 10.1016/j.jhlto.2025.100472
Jane Simanovski PhD, NP , Jody Ralph PhD, RN , Jamie Crawley PhD, RN , Kelly Bryce PhD , Dana Sleiman BScN, RN , Edward Cruz PhD, RN
{"title":"The unsung heroes: A scoping review of the experiences of lung transplant informal caregivers","authors":"Jane Simanovski PhD, NP , Jody Ralph PhD, RN , Jamie Crawley PhD, RN , Kelly Bryce PhD , Dana Sleiman BScN, RN , Edward Cruz PhD, RN","doi":"10.1016/j.jhlto.2025.100472","DOIUrl":"10.1016/j.jhlto.2025.100472","url":null,"abstract":"<div><div>Informal caregivers support patients after lung transplantation (LTx). With growing recognition of the multiple demands placed on caregivers, this scoping review aimed to systematically map the literature surrounding informal caregiving experiences after LTx using JBI guidelines. Multiple databases were searched from January 2010 to May 2025 based on a combination of synonyms and controlled vocabulary related to “caregiver” and “lung transplant recipients”. A total of 404 records were screened after the removal of duplicates. Among these, 16 sources met the inclusion criteria with 12 (75%) classified as full publications, 3 (19%) peer-reviewed conference abstracts, and 1 poster presentation. Most studies were based in North America (11/16 [69%]) with the remainder from Europe or Australia. Only 19% (3/16) of the sources were published within the past 5 years. There were 7 qualitative studies (44%), 6 quantitative (38%), 2 mixed methods (12%), and 1 literature review. Informal caregivers described a wide variety of challenges ranging from high levels of caregiver burden, psychological and emotional impacts, handling multiple daily practicalities, knowledge deficits, and the need for more support. Positive experiences of the informal caregiver role include positive adjustment, presence of support networks and relationships, improved quality of life, and benefiting from educational support and preparation. Informal caregivers remain an integral resource in supporting patients after LTx. However, most available evidence predates recent advances in transplantation practice—with 80% published before 2020—limiting its current relevance and highlighting the need for further research and targeted interventions to support this population.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"11 ","pages":"Article 100472"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145975964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-02-01Epub Date: 2025-10-15DOI: 10.1016/j.jhlto.2025.100412
Etienne Revelly , André Denault , Alex Moore
{"title":"Right ventricular function assessment by transesophageal echocardiography in lung transplantation: Preoperative, intraoperative, and postoperative considerations","authors":"Etienne Revelly , André Denault , Alex Moore","doi":"10.1016/j.jhlto.2025.100412","DOIUrl":"10.1016/j.jhlto.2025.100412","url":null,"abstract":"<div><h3>Background</h3><div>Right ventricular (RV) function is a key determinant of outcomes in lung transplantation, particularly in patients with pre-existing pulmonary hypertension. The RV is uniquely sensitive to perioperative hemodynamic stressors, including ischemia-reperfusion injury, abrupt afterload changes, and allograft implantation.</div></div><div><h3>Purpose</h3><div>This review aims to summarize the perioperative echocardiographic assessment of RV function in lung transplantation, emphasizing the role of transesophageal echocardiography (TEE) in evaluating RV performance and guiding intraoperative management.</div></div><div><h3>Methods</h3><div>A comprehensive synthesis of recent literature was performed, focusing on echocardiographic parameters relevant to RV evaluation during the preoperative, intraoperative, and postoperative phases of lung transplantation. Both conventional and advanced imaging modalities were reviewed.</div></div><div><h3>Discussion</h3><div>TEE provides real-time insights into RV adaptation and dysfunction. Key parameters include fractional area change, tricuspid annular plane systolic excursion (TAPSE), tricuspid annular velocity (S’), and speckle-tracking–derived strain. Three-dimensional echocardiography enhances volumetric and geometric assessment, while venous congestion indices such as the Venous Excess Ultrasound (VExUS) score offer indirect hemodynamic evaluation. Intraoperatively, dynamic monitoring supports optimization of preload, afterload, and inotrope therapy. Postoperative complications—such as RV outflow tract obstruction and pulmonary vascular anastomotic dysfunction—require prompt recognition. Persistent RV dysfunction despite afterload reduction may reflect intrinsic myocardial disease.</div></div><div><h3>Conclusion</h3><div>Comprehensive echocardiographic evaluation throughout all perioperative phases is essential for optimizing RV performance and improving outcomes in lung transplantation. Future studies should aim to standardize RV assessment protocols and validate multimodal imaging approaches for perioperative clinical decision-making.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"11 ","pages":"Article 100412"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145469028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
JHLT OpenPub Date : 2026-02-01Epub Date: 2025-10-17DOI: 10.1016/j.jhlto.2025.100411
Raphaël Giraud , Selina Adam , Benjamin Assouline , Franziska Beyeler , Roger Hullin , Karim Bendjelid , Franz Immer
{"title":"Optimizing recovery of marginal donor hearts with low ejection fraction: A national retrospective study from Switzerland","authors":"Raphaël Giraud , Selina Adam , Benjamin Assouline , Franziska Beyeler , Roger Hullin , Karim Bendjelid , Franz Immer","doi":"10.1016/j.jhlto.2025.100411","DOIUrl":"10.1016/j.jhlto.2025.100411","url":null,"abstract":"<div><h3>Background</h3><div>In Switzerland, heart transplantation is limited by donor availability. Marginal donor hearts—characterized by older age, comorbidities, or reduced left ventricular ejection fraction (LVEF)—are often declined despite being structurally normal. Since impaired LVEF may be reversible, optimized donor management could improve cardiac function and transplant eligibility.</div></div><div><h3>Methods</h3><div>This retrospective cohort study analyzed 415 brain-dead donors (2017–2021) from the Swiss Organ Allocation System. Donors were categorized as optimal (LVEF ≥50%) or marginal (LVEF 15–49%), irrespective of structural abnormalities, to focus on a modifiable functional parameter. Predictors of heart transplantation were assessed using univariate and multivariable logistic regression. Additional analyses evaluated hemodynamic monitoring, diagnostic strategies, management duration, and functional recovery based on serial echocardiography.</div></div><div><h3>Results</h3><div>Among 415 donors, 287 were optimal and 62 marginal. Transplantation rates were higher in optimal hearts (62.7% vs. 23.6%, p < 0.001). LVEF ≥50% independently predicted transplantation (adjusted OR = 4.56; 95% CI: 2.34–8.89; p < 0.001), together with younger age, lower norepinephrine dose, central monitoring, and repeated echocardiography. Marginal hearts demonstrated significant improvement in LVEF after optimized management (p < 0.0001), suggesting that reversible dysfunction can be mitigated through tailored hemodynamic and pharmacologic strategies.</div></div><div><h3>Conclusions</h3><div>Optimized donor management can restore left ventricular function in marginal hearts and enhance transplant eligibility. Standardized national guidelines may help expand the donor pool and improve transplantation outcomes.</div></div>","PeriodicalId":100741,"journal":{"name":"JHLT Open","volume":"11 ","pages":"Article 100411"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145469086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}